-
Healthy Habits
Ripe for the PickingAwareness of the link between cancer risk and a diet lacking fruits and vegetables has been declining.
by Carisa D. Brewster
-
Forward Look
Cancer Screening for the LGBTQ CommunityFear of discrimination may lead to lower screening rates.
by Tara Santora
-
Forward Look
What’s Next? Fall 2020A therapeutic vaccine targeting advanced cervical cancer.
by Anna Azvolinsky
-
Worth the Wait
Neoadjuvant therapy—using treatments such as chemotherapy, hormone therapy or radiation to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients.
by Sharon Tregaskis
-
Facts and Stats
A Brief History of Checkpoint InhibitorsThe advent of checkpoint inhibitors has broadened the range of cancer patients able to take advantage of immunotherapy.
by Bradley Jones
-
Targeted Therapy for Early-Stage Lung Cancer?
A trial of the targeted therapy Tagrisso (osimertinib) for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion.
by Ashley P. Taylor
-
Cervical Cancer Screening Guideline Updated
A new version of the American Cancer Society's cervical cancer screening guideline says screening can start at a later age and highlights human papillomavirus testing as the preferred method.
by Anna Azvolinsky
-
Support Grows for Making Transfusions a Part of Hospice
Blood cancer patients have low rates of enrollment in hospice. One barrier to enrollment is that many hospices do not provide blood transfusions.
by Jon Kelvey
-
Anal Cancer Diagnoses and Deaths Are Rising in the U.S.
Study underscores importance of early detection and prevention.
by Jane Langille
-
In It for the Long Haul
Doctors and researchers met online to discuss how the coronavirus pandemic changed cancer care in its early months, as well as how they can improve care and advocate for patients going forward.
by Kate Yandell
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff